Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025

(Image credit: ©pillerss/AdobeStock)

Alcon, Johnson & Johnson and Bausch + Lomb announced upcoming presentations at the 43^rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) being held 12-15 September in Copenhagen, Denmark. From technologies in cataract, refractive and glaucoma, to new IOLs, the companies will be presenting new information on clinical data and innovations.

Alcon at ESCRS 2025

Alcon will present more than 40 studies alongside new technologies in cataract, refractive and glaucoma during the 2025 ESCRS meeting. Additionally, the company will host various symposia and activities.¹

Alcon’s latest technologies available in Europe highlighted at ESCRS 2025

• Offering first-to-market innovations, the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) are both designed to deliver efficiency, allowing for the transformation of vitreoretinal and cataract surgery.¹
• The Clareon Vivity IOL is newly commercially available in Europe. Vivity, offering presbyopia correction with a consistent monofocal visual disturbance profile, is the most implanted extended depth of focus (EDOF) IOL worldwide, completing the Clareon Collection.¹
• The first and only Direct Selective Laser Trabeculoplasty (DSLT) device, Voyager DSLT simplifies selective laser trabeculoplasty by streamlining practice workflows. It is designed to deliver an “exceptional” experience for patients, helping to accelerate the adoption of laser as a first-line therapy.¹
• Intelligent Service Solutions is launching globally, enabling remote diagnostics and software updates to allow for maximised customer productivity. Customers can find a comprehensive dashboard of Alcon devices and information, including warranty information, contract details, and device connectivity overview.¹

“As ophthalmic practices face rising procedural volumes and increasing pressure to deliver both precision and efficiency, Alcon remains committed to providing integrated solutions that elevate every stage of the surgical journey,” Sunil Vasanth, Vice President Surgical, Alcon Europe, said in a press release.

“With the launch of UNITY VCS, the completion of our Clareon IOL portfolio, and a growing body of clinical evidence to support their use, we’re empowering surgeons with a comprehensive, connected platform designed to streamline workflows and deliver exceptional outcomes for patients across a broad range of needs," Vasanth said.

Alcon announces positive outcome data for its surgical portfolio

More than 40 studies will be presented by Alcon over the course of the meeting.

New results of Vivity EDOF IOL studies across more than 10 clinical studies and more than 700 patients will be showcased. These new results demonstrate positive outcomes and/or patient satisfaction following Vivity IOL implantations in special populations.

1. Dr Antonia Cartabellotta will present spectacle independence and dysphotopsia data in cataract patients with early-to-intermediate dry age-related macular degeneration (AMD).¹
2. Findings from bilateral implantation in cataract patients with mild corneal irregularities, such as keratoconus, will be presented by Dr Erika Bonacci.¹
3. Results of EDOF IOL implantation in patients with mild irregular astigmatism will be presented by Dr Daniel Schartmüller Sunday, 14 Sept. at 9:15 CEST.¹

New data on the UNITY VCS and studies highlighting the benefits of operating at more physiologic IOP, including reduced use of breakthrough pain medication.¹

1. An evaluation of surgeon performance when using UNITY VCS versus CENTURION Vision System with Active Sentry will be presented by Dr Kevin Miller Tuesday, 16 September at 9:55-10:00 CEST, at the Free Paper Podium 4.
2. Early single-arm data from UNITY VCS demonstrating accurate IOP control, validated and supported by video analysis, will be presented by Dr Vance Thompson.
3. Anterior chamber stability during cataract surgery using UNITY VCS compared to CENTURION with Active Sentry will be presented by Dr Hisharu Suzuki Saturday, 13 September, 15:05 CEST, at Balcony 2, Presented Poster Pod 1.
4. Data on patient comfort and intraoperative medications when operating at more physiologic IOP during cataract surgery with CENTURION with Active Sentry will be showcased by Dr Matthew Rauen Saturday, 13 Sept. at Balcony 2, Presented Poster Pod 1, and Tuesday, 16 Sept., 08:45-08:50 CEST, Free Paper Podium 4.

Alcon will also host a symposium on “Optimising cataract surgery: Focus on real-world experience with near physiologic IOP,” on with Moderator Gábor Scharioth (Germany), and faculty members David Lockington (UK), Cristina Peris-Martinez (Spain) and Matthew Rauen (US).

Alcon presents refractive technology outcomes

Two presentations will highlight better outcomes compared to more commonly used technologies. Dr John Kanellopoulos will highlight results supporting visual outcomes with ray-tracing-guided LASIK using Alcon’s wavelight plus, compared to lenticule extraction (SMILE Pro, Zeiss) for myopia correction. And Dr Ramin Khoramnia will present efficacy and safety data comparing automated ray-tracing-guided LASIK using Alcon’s wavelight plus, compared to wavefront-optimised LASIK.¹

Other symposium sessions hosted by Alcon include sessions highlighting UNITY VCS|CS and Advanced Technology IOLs, as well as live surgery presentations showcasing Hydrus Microstent and Clareon Vivity IOL and Voyager DSLT.¹

Bausch + Lomb at ESCRS 2025

Bausch + Lomb has 35 data presentations and posters on deck for ESCRS 2025.

Highlights include a Spotlight Presentation on the company’s enVista Envy IOL, as well as study results evaluating technologies such as LuxLife and enVista Aspire IOLs, the ELIOS procedure for glaucoma treatment and new dry eye data from a multinational survey.²

Bausch + Lomb presentations

Saturday, 13 September

Lunchtime Symposium: Inspired by the Natural Wonder of the Northern Lights - A New Dawn in Ophthalmic Surgery Innovation

• 13:00-14:00, Auditorium 10
• Speakers: Dr Cathleen McCabe, Prof Suphi Taneri, Associate Prof Christina Leydolt, Dr Francesco Carones and Dr Ana Miguel
• Join a panel of experts as they discuss their experience with Bausch + Lomb technologies including the OCTAVIUS customised corneal treatment and transEpi PRK procedure with the Teneo M2; the enVista Aspire and LuxLife premium IOLs and the ELIOS procedure for the treatment of glaucoma.

A Spotlight on Dry Eye Disease in Ocular Surgery

• 18:00-20:00, Scandic Spectrum Hotel, Copenhagen
• Speakers: Dr Elisabeth Messmer, Dr Wassim Altroudi, Dr Piotr Wozniak and Dr Lisa Nijm
• Leading ophthalmologists will share their clinical experience of dry eye management in ocular surgery. Following the presentations, attendees will also have the opportunity to view our innovation stand and congress poster portfolio and engage in an open discussion and share best practices.
• Please register here.

Sunday, 14 September

IME Session: Modern Presbyopia Correction – Innovations in IOL Technology and Customised Patient Planning

• 9:30-10:45; Room D4
• Mr Jonathan Yu from the United Kingdom will present a case study on the LuxLife IOL.

Lift off: Innovation Meets Inspiration

• 18:30-22:30, SMK National Gallery, Solvgade 48-50,1307 Indre By, Copenhagen (buses depart the congress center at 18:00)
• Attendees can connect with a natural visual experience during this experience celebrating the wonder of the Northern Lights. Take advantage of this opportunity to network with peers and learn about the latest innovations from Bausch + Lomb.

Spotlight Abstract

• “Safety and Performance of a Novel Full Visual Range Intraocular Lens: US Pivotal Clinical Study.” McCabe C.

Paper Presentations

• “Influence of Residual Astigmatism on Patient Satisfaction and Dysphotopsias After Implantation of a Novel Full Range of Vision IOL.” Muzychuk A.
• “Clinical Outcomes of a Novel Full Range of Vision Intraocular Lens at 6- and 12-Months After Bilateral Implantation.” Castro FJ.
• “Visual Outcomes and Depth of Focus from Ray Tracing Aberrometry in Small Aperture Optics Intraocular Lens in Eyes with Aberrated Corneas.” Klyce S.
• “Early Outcomes of Transepithelial Photorefractive Keratectomy (tPRK) with PROSCAN Aspheric Treatment Compared with OCTAVIUS Topography-Optimized Treatment.” Tagal J.
• “Correction of High Myopia with Laser in Situ Keratomileusis Performed Using an Advanced Excimer Laser System with an Aspheric Ablation Algorithm.” Stonecipher K.
• “Real-World Outcomes of LASIK Using a Novel FDA-Approved Advanced Excimer Laser with Aspheric Ablation Profile for the Correction of Myopia and Myopic Astigmatism.” Waring G.
• “Combined Phaco-Excimer Trabeculostomies: Up to 24 Month Follow-Up.” Grise-Dulac A.
• “Systematic Review and Meta-Analysis of the Long-Term Efficacy and Safety of Excimer Laser Trabeculostomy.” Gazard G.

Presented Posters

• “Dry Eye Symptoms, Severity, Treatment and Unmet Needs: An Analysis of the United States and a Multinational Snapshot.” Wozniak P.
• “The Resta Study: A Comparison of Two Preservative-Free Artificial Tears with Sodium Hyaluronate for Relief of Dry Eye.” Labetoulle M.
• “Visual Outcomes and Rotational Stability Following Implantation of a New Partial Range of Field Toric Enhanced IOL.” Mingo Botin D.
• “Evaluation of Visual Performance in Patients Implanted with a New Partial Range of Field Enhanced Intraocular Lens.” Castro FJ.
• “Optical Performance and Refractive Outcomes of a New Monofocal Intraocular Lens with Intermediate Optimized Optics.” Rocha K.
• “A Non-Interventional, Prospective, Clinical Study of the Performance of an Enhanced Monofocal Intraocular Lens in Patients Undergoing Cataract Surgery: Interim Analysis.” Donnenfeld E.
• “Retrospective Real-World Evidence Study: User Experience with a Toric and Non-Toric Full Range of Vision Intraocular Lens.” Katz J.
• “Retrospective Real-World Evidence Study: Performance of a Full Range of Vision, Toric Intraocular Lens in Patients Undergoing Cataract Surgery.” Harasymowycz P.
• “Improving Cataract Surgery Outcomes Using a Novel IOL Planning Software and Digital Guidance.” Lobanoff M.
• “Visual Outcomes Following Removal of Corneal Inlay and Implantation of a Small-Aperture Intraocular Lens During Cataract Surgery.” Ang R.
• “Efficacy and Safety of Excimer Laser Trabeculostomy (ELT), a Laser-Based Trabecular Minimally Invasive Glaucoma Surgery (MIGS) Combined with Phacoemulsification Surgery.” Moreno A.
• “First Outcomes of Combined Phaco-Emulsification with Excimer Laser Trabeculostomy in Patients with Glaucoma in the Netherlands.” de Crom R.
• “Visual Performance of Negative Versus Neutral Aspheric Monofocal Intraocular Lenses in Light and Dark Conditions: A Randomized Controlled Trial.” Pantanelli SM.
• “Evaluation of a Novel Preservative-Free Formulation of Brimonidine Tartrate.” Balidis M.

Posters

• “Visual Outcomes, Spectacle Independence and Patient-Reported Visual Symptoms Following the Implantation of a New Enhanced Monofocal IOL with Intermediate Optimized Optics.” Mahootchi A.
• “Early Postoperative 1-Hour Outcomes of a Novel Enhanced Monofocal IOL with Intermediate Optimized Optics Implanted in Patients Undergoing Cataract Surgery.” Stonecipher K.
• “Real-World Evaluation of the Visual Performance and Patient Satisfaction with a Novel Full Range of Vision Toric Intraocular Lens.” Muzychuk A.
• “Retrospective Real-World Evidence Study: Performance of a Full Range of Vision, Non-Toric Intraocular Lens in Patients Undergoing Cataract Surgery.” Lobanoff M.
• “Mesopic Visual Acuity Evaluation After Cataract Surgery in Patients Implanted with a Novel Full Visual Range Intraocular Lens.” Shultz M.
• “Risk Factors for YAG Capsulotomy Following IC-8 Implantation.” Mehta J.
• “Bilateral Implantation of the IC-8 Small Aperture IOL in a Post-Radial Keratotomy Patient: A Case Report.” Costantini F.
• “Clinical Outcomes of the Presbyopic Laser Treatment SUPRACOR in Hyperopic and Myopic Eyes.” Ang R.
• “Clinical Outcomes of an Excimer Laser Trabecular Bypass Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery in Patients with Primary Open Angle Glaucoma.” Singh P.
• “Clinical Outcomes of an Excimer Laser Trabecular Bypass Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery in Patients with Ocular Hypertension.” McCabe C.
• “The Prevalence of Hyperosmolarity and Its Influence on Light Scatter in Patients Undergoing Cataract Surgery.” Nijm L.
• “A Multi-Country Assessment of Eye Care Professionals’ Perspectives on the Conjunctival Hyperaemia Treatment Landscape.” Ziakas N.

Johnson & Johnson presenting at ESCRS 2025

Johnson & Johnson announced the presentation of new data on the TECNIC IOL platform’s performance across diverse patient needs.³

“We’re proud to share new clinical data at ESCRS that reinforces the proven performance of our TECNIS platform – delivering reliable, high-quality visual outcomes tailored to cataract patients’ everyday needs, and enhancing lives through exceptional vision,” Jacqueline Henderson, President Vision EMEA, Johnson & Johnson, said in a press release.³ “At Johnson & Johnson, we’re constantly seeking to redefine what’s possible in cataract care and remain committed to empower surgeons with precision-driven solutions that support personalised care across a diverse range of refractive profiles and lifestyles.”

J&J presentations highlighting the TECNIS platform at ESCRS 2025

“Visual and Refractive Outcomes in Patients with a History of Previous Laser Vision Correction Undergoing Implantation of a Refractive Partial Range of Field Extended Intraocular Lens,” presented by Stephen Stewart, will highlight how a new, refractive partial range of field extended IOL offered good range of vision with minimal side effects. Additionally, further analysis on previous hyperopic or myopic surgery type results from an additional 30 bilateral LVC patients at 3 months will also be presented.³

Dr Helena Noguera will present, “Comparison of Visual Outcomes and Defocus Curves Between the Purely Refractive Partial Range of Field Extended IOL TECNIS PureSee IOL and the TECNIS 1-Pieces IOL.” This presentation will illustrate data found to support the TECNIS PureSee IOL offering positive intermediate and near vision without compromising distance vision and maintaining a more stable defocus curve when compared to the monofocal IOL. Additionally, no halos or glare were reported in either group, despite theoretical risks about photopic disturbances.3

Data on the TECNIC IOL portfolio will be presented by Karolinne Rocha, Md, PhD, in a presentation titled, “Tolerance to Induced Astigmatism Amongst Various Intraocular Lenses Categories.” According to highlights from this presentation, the TECNIC IOL was evaluated for tolerance with astigmatism across standard monofocal, enhanced monofocal, diffractive EDOF, and diffractive multifocal IOLs. Findings showed better tolerance to induced oblique and against-the-rule astigmatism in enhanced monofocal IOL group compared to the other types. Lastly, it is noted that overall, with-the-rule astigmatism was better tolerated than oblique and against-the-rule in all groups.

An e-poster presentation, “Systematic Review and Meta-Analysis of Enhanced versus Monofocal Intraocular Lenses in Cataract Surgery,” will be showcased by Dr Joaquin Fernandez. This e-poster will highlight the meta-analysis for TECNIS Eyhance IOL, which found high-certainty evidence that the IOL enhances intermediate and near visual acuity compared to standard monofocal IOLs. Additionally, evidence for contrast sensitivity and patient-reported outcomes was moderate to low, though further research is needed on other new enhanced monofocal IOLs to confirm outcomes in comparison to TECNIS Eyhance IOL.

J&J to participate in interactive educational forums and events during ESCRS

• J&J Vision IOL Innovation Summit: TECNIS Odyssey™ IOL & TECNIS PureSee™ IOL. 12 September at 19:00-20:30 CET. Location: Crown Plaza Ground Floor Everest. Room 3.
• Vision Beyond Limits: Meet the EDOF Experts: 13 September at 10:30-11:00 CET. Location: Johnson & Johnson Stand E.040 - Bella Congress Centre.
• Innovating Clarity: Freeform Technology for High Spectacle Independence: 13 September at 13:00-14:00 CET. Location: Bella Congress Centre Room D4.
• A Quest for High Spectacle Independence: 13 September at 15:00-15:30 CET. Location: Johnson & Johnson Stand E.040 - Bella Congress Centre.
• Innovating Patient Care: The Clinical Advantages and Economic Impacts of an Enhanced Monofocal IOL: 14 September at 10:30-11:00 CET. Location: Johnson & Johnson Stand E.040 - Bella Congress Centre.
• TECNIS™ IOL COMPASS: Exploring Technology and Navigating Supreme Patient Care: 14 September at 13:00-14:00 CET. Location: Bella Congress Centre. Room D5.
• Tips and Tricks for Best SILK™ Practices: 14 September at 15:00-15:30 CET. Location: Johnson & Johnson Stand E.040 - Bella Congress Centre.

Reference:

1. Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025. Published Sept. 8, 2025. Accessed Sept. 9, 2025. https://www.businesswire.com/news/home/20250905764532/en/Alcon-Launches-Groundbreaking-Innovations-and-Highlights-New-Study-Findings-at-ESCRS-2025

2. Bausch + Lomb Announces New Scientific Data, Educational Events at the European Society of Cataract and Refractive Surgery Annual Meeting. Published Sept. 2, 2025. Accessed Sept. 9, 2025.

3. Johnson & Johnson Showcases New Data for TECNIS IOLs at ESCRS 2025. Published Sept. 4, 2025. Accessed Sept. 9, 2025. https://www.jnjmedtech.com/en-EMEA/news-events/johnson-johnson-showcases-new-data-tecnis-iols-escrs-2025